Neuro-Oncology Reviews

Volume 24 Number 9
15 May 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 9, 15 May

Narita Y.
[Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives].
Brain Nerve. 2022 May 1;74(5):668-676→. Japanese. doi: 10.11477/mf.1416202095→. PMID: 35589662→. Review˰ ˍ

Qiao L, Yang H, Shao XX, Yin Q, Fu XJ, Wei Q.
Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma.
Mol Pharm. 2022 May 2→. doi: 10.1021/acs.molpharmaceut.1c00856→. PMID: 35499303→. Review˰ ˍ

Fang FY, Rosenblum JS, Ho WS, Heiss JD.
New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.
Cancers (Basel). 2022 May 3;14(9):2285→. doi: 10.3390/cancers14092285→. PMID: 35565414→. Review. ˍ

Pepper NB, Stummer W, Eich HT.
The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.
Strahlenther Onkol. 2022 May 3;198(6):507-526→. doi: 10.1007/s00066-022-01942-1→. PMID: 35503461→. Review˰ ˍ

Antonucci L, Canciani G, Mastronuzzi A, Carai A, Del Baldo G, Del Bufalo F.
CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Front Immunol. 2022 May 4;13:867154→. doi: 10.3389/fimmu.2022.867154→. PMID: 35603195→. Review. ˍ

Chandrasekar G, Bansal VS, Panigrahi M, Kitambi SS.
An overview of targets and therapies for glioblastoma multiforme.
J Cancer Res Ther. 2022 May 4, 2022;18(3):591-598→. doi: 10.4103/jcrt.jcrt_1324_21→. PMID: 35900527→. Review. ˍ

Da-Veiga MA, Rogister B, Lombard A, Neirinckx V, Piette C.
Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives.
Cancers (Basel). 2022 May 4;14(9):2296→. doi: 10.3390/cancers14092296→. PMID: 35565425→. Review. ˍ

Samples DC, Mulcahy Levy JM, Hankinson TC.
Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management.
Front Surg. 2022 May 4;9:884250→. doi: 10.3389/fsurg.2022.884250→. PMID: 35599811→. Review. ˍ

Zeng Z, Chen Y, Geng X, Zhang Y, Wen X, Yan Q, Wang T, Ling C, Xu Y, Duan J, Zheng K, Sun Z.
NcRNAs: Multi-angle participation in the regulation of glioma chemotherapy resistance (Review).
Int J Oncol. 2022 May 4;60(6):76→. doi: 10.3892/ijo.2022.5366→. PMID: 35506469→. Review. ˍ

Giussani C, Trezza A, Ricciuti V, Di Cristofori A, Held A, Isella V, Massimino M.
Intraoperative MRI versus intraoperative ultrasound in pediatric brain tumor surgery: is expensive better than cheap? A review of the literature.
Childs Nerv Syst. 2022 May 5→. doi: 10.1007/s00381-022-05545-0→. PMID: 35511271→. Review˰ ˍ

Malbari F, Gill J, Daigle A, Rodriguez LL, Raghubar KP, Davis KC, Scheurer M, Ma MM, Kralik SF, Meoded A, Okcu MF, Chintagumpala MM, Aldave G, Weiner HL, Kahalley LS.
Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
Pediatr Neurol. 2022 May 5;132:4-10→. doi: 10.1016/j.pediatrneurol.2022.04.014→. PMID: 35598587→. Review˰ ˍ

Pedersen C, Aboian M, McConathy JE, Daldrup-Link H, Franceschi AM.
PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice.
Am J Neuroradiol. 2022 May 5→. doi: 10.3174/ajnr.A7464→. PMID: 35512826→. Review. ˍ

Perez WD, Perez-Torres CJ.
Neurocognitive and radiological changes after cranial radiation therapy in humans and rodents: A systematic review.
Int J Radiat Biol. 2022 May 5:1-54→. doi: 10.1080/09553002.2022.2074167→. PMID: 35511499→. Review˰ ˍ

Gupta T, Talukdar R, Kannan S, Dasgupta A, Chatterjee A, Patil V.
Efficacy and safety of extended adjuvant temozolomide compared to standard adjuvant temozolomide in glioblastoma: Updated systematic review and meta-analysis.
Neurooncol Pract. 2022 May 7;9(5):354-363→. doi: 10.1093/nop/npac036→. PMID: 36134016→. Review, Meta-analysis. ˍ

Piccardo A, Albert NL, Borgwardt L, Fahey FH, Hargrave D, Galldiks N, Jehanno N, Kurch L, Law I, Lim R, Lopci E, Marner L, Morana G, Young Poussaint T, Seghers VJ, Shulkin BL, Warren KE, Traub-Weidinger T, Zucchetta P.
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0.
Eur J Nucl Med Mol Imaging. 2022 May 10→. doi: 10.1007/s00259-022-05817-6→. PMID: 35536420→. Guidelines. ˍ

Shafi O, Siddiqui G.
Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review.
World J Surg Oncol. 2022 May 10;20(1):146→. doi: 10.1186/s12957-022-02602-5→. PMID: 35538578→. Review. ˍ

Afonso M, Brito MA.
Therapeutic Options in Neuro-Oncology.
Int J Mol Sci. 2022 May 11;23(10):5351→. doi: 10.3390/ijms23105351→. PMID: 35628161→. Review. ˍ

Bander ED, Knisely JPS, Schwartz TH.
Brachytherapy for central nervous system tumors.
J Neurooncol. 2022 May 11→. doi: 10.1007/s11060-022-04026-3→. PMID: 35546384→. Review˰ ˍ

Baro V, Cerretti G, Todoverto M, Della Puppa A, Chioffi F, Volpin F, Causin F, Busato F, Fiduccia P, Landi A, d'Avella D, Zagonel V, Denaro L, Lombardi G.
Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.
Curr Oncol. 2022 May 11;29(5):3472-3488→. doi: 10.3390/curroncol29050280→. PMID: 35621670→. Review. ˍ

Chen J, Han P, Dahiya S.
Glioblastoma: Changing concepts in the WHO CNS5 classification.
Indian J Pathol Microbiol. 2022 May 11;65(Supplement):S24-S32→. doi: 10.4103/ijpm.ijpm_1109_21? PMID: 35562131→. Review. ˍ

Gianno F, Miele E, Antonelli M, Giangaspero F.
Embryonal tumors in the WHO CNS5 classification: A Review.
Indian J Pathol Microbiol. 2022 May 11;65(Supplement):S73-S82→. doi: 10.4103/ijpm.ijpm_1049_21? PMID: 35562137→. Review. ˍ

Mahajan S, Suri V, Sahu S, Sharma MC, Sarkar C.
World Health Organization Classification of Tumors of the Central Nervous System 5^th Edition (WHO CNS5): What's new?
Indian J Pathol Microbiol. 2022 May 11;65(Supplement):S5-S13→. doi: 10.4103/ijpm.ijpm_48_22? PMID: 35562129→. Review. ˍ

Rao S, Sahay A, Epari S.
Paediatric type diffuse high grade gliomas in the WHO CNS5 classification: What the pathologist needs to know?
Indian J Pathol Microbiol. 2022 May 11;65(Supplement):S50-S58→. doi: 10.4103/ijpm.ijpm_1202_21? PMID: 35562134→. Review. ˍ

Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2022 May 11→. NCBI Bookshelf ID: NBK65954→. PMID: 26389391→. Review. ˍ

Sabu A, Liu TI, Ng SS, Doong RA, Huang YF, Chiu HC.
Nanomedicines Targeting Glioma Stem Cells.
ACS Appl Mater Interfaces. 2022 May 11→. doi: 10.1021/acsami.2c03538→. PMID: 35544684→. Review˰ ˍ

Santosh V, Rao S.
A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
Indian J Pathol Microbiol. 2022 May 11;65(Supplement):S14-S23→. doi: 10.4103/ijpm.ijpm_34_22? PMID: 35562130→. Review. ˍ

van de Weijer T, Broen MPG, Moonen RPM, Hoeben A, Anten M, Hovinga K, Compter I, van der Pol JAJ, Mitea C, Lodewick TM, Jacquerie A, Mottaghy FM, Wildberger JE, Postma AA.
The Use of ¹⁸F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds-A Narrative Review.
Diagnostics (Basel). 2022 May 11;12(5):1202→. doi: 10.3390/diagnostics12051202→. PMID: 35626357→. Review. ˍ

Arakawa Y, Mineharu Y, Uto M, Mizowaki T.
Optimal managements of elderly patients with glioblastoma.
Jpn J Clin Oncol. 2022 May 12:hyac075→. doi: 10.1093/jjco/hyac075→. PMID: 35552425→. Review˰ ˍ

McMahon JT, Studer M, Ulrich B, Revuelta Barbero JM, Pradilla I, Palacios-Ariza MA, Pradilla G.
Circulating Tumor DNA in Adults With Glioma: A Systematic Review and Meta-Analysis of Biomarker Performance.
Neurosurgery. 2022 May 12→. doi: 10.1227/neu.0000000000001982→. PMID: 35535984→. Review, Meta-analysis˰ ˍ

Motomura K, Ohka F, Aoki K, Saito R.
Supratotal Resection of Gliomas With Awake Brain Mapping: Maximal Tumor Resection Preserving Motor, Language, and Neurocognitive Functions.
Front Neurol. 2022 May 12;13:874826→. doi: 10.3389/fneur.2022.874826→. PMID: 35645972→. Review. ˍ

Wu J, Al-Zahrani A, Beylerli O, Sufianov R, Talybov R, Meshcheryakova S, Sufianova G, Gareev I, Sufianov A.
Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
Front Oncol. 2022 May 12;12:898537→. doi: 10.3389/fonc.2022.898537→. PMID: 35646622→. Review. ˍ

Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I.
Epidemiology of Glioblastoma Multiforme-Literature Review.
Cancers (Basel). 2022 May 13;14(10):2412→. doi: 10.3390/cancers14102412→. PMID: 35626018→. Review. ˍ

Verma A, Rafiq S.
Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.
Cancer Treat Res. 2022 May 13;183:161-184→. doi: 10.1007/978-3-030-96376-7_5→. PMID: 35551659→. Review˰ ˍ

Vilar JB, Christmann M, Tomicic MT.
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Cancers (Basel). 2022 May 13;14(10):2416→. doi: 10.3390/cancers14102416→. PMID: 35626024→. Review. ˍ

Hertler C.
Palliative care implementation in neuro-oncology-Where do we come from, where do we go?
Neurooncol Pract. 2022 May 14;9(4):257-258→. doi: 10.1093/nop/npac039→. PMID: 35859539→. Editorial˰ ˍ

Kannan S, Murugan AK, Balasubramanian S, Munirajan AK, Alzahrani AS.
Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options.
Biochem Pharmacol. 2022 May 14;201:115090→. doi: 10.1016/j.bcp.2022.115090→. PMID: 35577014→. Review˰ ˍ

López-Pérez CA, Franco-Mojica X, Villanueva-Gaona R, Díaz-Alba A, Rodríguez-Florido MA, Navarro VG.
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.
J Neurooncol. 2022 May 14→. doi: 10.1007/s11060-022-04024-5→. PMID: 35567713→. Review˰ ˍ